
Anthony Aldave, MD, explains when cataract extraction should be done alone or with Descemet's stripping automated endothelial keratoplasty (DSAEK).
Anthony Aldave, MD, explains when cataract extraction should be done alone or with Descemet's stripping automated endothelial keratoplasty (DSAEK).
The recent issuance of revised recommendations for hydroxychloroquine retinopathy screening from the American Academy of Ophthalmology will have substantial effects on practicing ophthalmologists.
Advances in ophthalmic surgery, especially vitreous suction-cutting devices, have made the treatment of congenital cataracts in the pediatric poulation easier and more effective.
A new premium daily disposable contact lens from Bausch + Lomb is made from a proprietary material that combines the features of conventional hydrogel and silicone hydrogel material.
The burden of retinopathy of prematurity (ROP) is great, and researchers are still working to find the most effective and safest treatments, said David Barañano, MD, PhD, at the 24th annual Current Concepts in Ophthalmology meeting.
Using interferon alpha-2b systemically for the treatment of refractory uveitic cystoid macular edema may be helpful in carefully selected patients.
Adoption of electronic health record technology has been slow, particularly among ophthalmologists.
Topical branded nonsteroidal anti-inflammatory drugs are safe to use in patients with evaporative dry eye syndrome and in those with meibomian gland dysfunction.
Tear osmolarity is well correlated to visual function, and may also be a key marker of dry eye disease
Cataract surgery can be beneficial in patients with low vision.
Careful use of anti-vascular endothelial growth factor agents for the treatment of age-related macular degeneration is acceptable, but physicians should be alert for exceptions to the expected outcome.
Some practical advice and common-sense tips can help clinicians stay abreast of developments and possible malpractice cases.
A new quinazolinone compound represents a novel approach to management of choroidal neovascularization.
Sustained release fluocinolone acetonide has the potential to become an effective long-term treatment for DME.
In patients who have not undergone previous treatment, bevacizumab appears to be a safe and effective treatment for exudative age-related macular degeneration.
Most aspects of ocular trauma are unique when practicing in a combat environment.
The use of a trabecular microbypass stent in combination with cataract surgery in patients with mild-to-moderate open-angle glaucoma is safe and results in clinically safe and statistically significant reductions in IOP with fewer medications when compared with cataract surgery alone.
Potential treatments for the management of dry age-related macular degeneration are numerous, but so far, studies still are ongoing as to their therapeutic benefit.
Pterygium recurrence rates may be significantly higher in Hispanic patients compared with Caucasian patients.
State-of-the-art evaluation and emerging therapies for retinal degenerations are currently the focus of significant research.
The association between cataract surgery and progression of age-related macular degeneration still is unclear.
A novel ophthalmic anti-allergy agent, epinastine HCl ophthalmic solution 0.05% (Elestat, Inspire Pharmaceuticals), effectively controls ocular allergy in patients with dry eye, according to Jodi Luchs, MD, FACS. The drop has been shown to rapidly prevent ocular allergy symptoms by blocking H1 and H2 receptors, stabilizing mast cells, and inhibiting the release of proinflammatory mediators.
Presentation is everything may be an adage that explains why display techniques and effects are perhaps the most important consideration when displaying eyeglass frames in a dispensary.
Charlotte, NC-The OcuLight Symphony Laser System (Iridex) is a revolutionary new system that has both visible and infrared light capabilities all in one unit.
For clinicians, the Internet can become a valuable tool for disseminating information on their practices and, ultimately, in attracting new patients.
Portland, OR-Nature's Tears EyeMist is a breakthrough product for the treatment of a variety of ocular irritations that delivers an ultra-fine mist of water to soothe and heal dry, irritated eyes, according to William D. Mathers, MD.
Published: September 15th 2004 | Updated:
Published: November 15th 2003 | Updated:
Published: January 1st 2004 | Updated:
Published: October 1st 2003 | Updated:
Published: April 15th 2011 | Updated:
Published: April 15th 2011 | Updated: